A Phase-III Noninferiority, Randomized Controlled Trial of Letibotulinum Toxin A for the Improvement of Moderate-to-Severe Glabellar Wrinkles in China

A Phase-III Noninferiority, Randomized Controlled Trial of Letibotulinum Toxin A for the Improvement of Moderate-to-Severe Glabellar Wrinkles in China

Background:. Letibotulinum toxin A has an established efficacy and safety profile for aesthetic treatment of glabellar wrinkles. This study was conducted to demonstrate the noninferiority of letibotulinum toxin A versus onabotulinum toxin A in improving the appearance of moderate-to-severe glabellar...

Full description

Bibliographic Details
Main Authors: Yun Xie, MD, Xiumin Yang, MD, PhD, Hong Liang, MD, PhD, Hongliang Bo, MD, PhD, Jianyun Lu, MD, PhD, Qing Guo, MD, Li Li, MD, PhD, Hyoung-jin Moon, MD, Qingfeng Li, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2024-01-01
Series:Plastic and Reconstructive Surgery, Global Open
Online Access:http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000005525

Internet

http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000005525

Similar Items